AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 230 filers reported holding AMICUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,802,867 | +7.3% | 290,517 | +0.4% | 0.00% | -50.0% |
| Q4 2022 | $3,545,346 | +16.6% | 289,416 | -0.4% | 0.00% | +100.0% |
| Q3 2022 | $3,040,000 | -56.7% | 290,510 | -53.9% | 0.00% | -66.7% |
| Q2 2022 | $7,013,000 | +102.0% | 630,723 | +75.0% | 0.00% | +50.0% |
| Q1 2022 | $3,471,000 | -21.9% | 360,405 | -2.3% | 0.00% | 0.0% |
| Q4 2021 | $4,447,000 | -6.7% | 369,077 | -25.1% | 0.00% | 0.0% |
| Q3 2021 | $4,766,000 | +78.8% | 492,901 | +94.5% | 0.00% | +100.0% |
| Q2 2021 | $2,665,000 | +19.1% | 253,367 | +5.0% | 0.00% | 0.0% |
| Q1 2021 | $2,237,000 | -58.5% | 241,313 | +1.7% | 0.00% | -75.0% |
| Q4 2020 | $5,385,000 | +500.3% | 237,320 | +280.4% | 0.00% | +300.0% |
| Q3 2020 | $897,000 | -21.7% | 62,393 | -13.7% | 0.00% | 0.0% |
| Q2 2020 | $1,145,000 | +16257.1% | 72,333 | +9442.6% | 0.00% | – |
| Q1 2020 | $7,000 | -99.2% | 758 | -99.2% | 0.00% | -100.0% |
| Q4 2019 | $910,000 | +402.8% | 93,398 | +314.5% | 0.00% | – |
| Q3 2019 | $181,000 | -89.7% | 22,530 | -83.9% | 0.00% | -100.0% |
| Q2 2019 | $1,749,000 | +37.1% | 140,172 | +49.4% | 0.00% | 0.0% |
| Q1 2019 | $1,276,000 | +3766.7% | 93,844 | +2637.6% | 0.00% | – |
| Q4 2018 | $33,000 | +73.7% | 3,428 | +117.9% | 0.00% | – |
| Q3 2018 | $19,000 | -57.8% | 1,573 | -46.0% | 0.00% | – |
| Q2 2018 | $45,000 | +32.4% | 2,914 | +27.1% | 0.00% | – |
| Q1 2018 | $34,000 | +3.0% | 2,292 | 0.0% | 0.00% | – |
| Q4 2017 | $33,000 | +1550.0% | 2,292 | +209.7% | 0.00% | – |
| Q2 2014 | $2,000 | – | 740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |